December 18th - 2004
If you or your child is taking Strattera for the treatment of ADD/ADHD, please read the following press release concerning possible liver damage. The actions taken by Eli Lilly, manufacturer of Strattera, were after "severe liver injury" was reported by two of the more than 2 million patients who have taken the medication since approval.
http://newsroom.lilly.com/ReleaseDetail.cfm?ReleaseID=150719
You know, if only 2 out of 2 million reported this problem, I would think that those 2 people either had a predispostion, or something else triggered the liver problems they experienced.